These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17488584)

  • 21. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
    Grommes C; Rubenstein JL; DeAngelis LM; Ferreri AJM; Batchelor TT
    Neuro Oncol; 2019 Feb; 21(3):296-305. PubMed ID: 30418592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity.
    Song KW; Batchelor T
    Curr Oncol Rep; 2021 Sep; 23(11):132. PubMed ID: 34524547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical features and treatment outcomes in primary central nervous system lymphoma: a descriptive analysis of 62 patients].
    Ge Y; Lin XT; Luo DL; Zhang F; Xu J; Li Z; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):861-866. PubMed ID: 31775435
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary central nervous system lymphoma.
    Citterio G; Reni M; Gatta G; Ferreri AJM
    Crit Rev Oncol Hematol; 2017 May; 113():97-110. PubMed ID: 28427529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary central nervous system lymphoma.
    Mohile NA; Abrey LE
    Neurol Clin; 2007 Nov; 25(4):1193-207, xi. PubMed ID: 17964031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
    Bojic M; Berghoff AS; Troch M; Agis H; Sperr WR; Widhalm G; Wöhrer A; Kalhs P; Preusser M; Rabitsch W
    Eur J Haematol; 2015 Jul; 95(1):75-82. PubMed ID: 25546348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary central nervous system lymphoma.
    Gavrilovic IT; Abrey LE
    Curr Oncol Rep; 2004 Sep; 6(5):388-95. PubMed ID: 15291982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The possible role of maintenance treatment for primary central nervous system lymphoma.
    Bairey O; Siegal T
    Blood Rev; 2018 Sep; 32(5):378-386. PubMed ID: 29551465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and opportunities in primary CNS lymphoma: A systematic review.
    Kerbauy MN; Moraes FY; Lok BH; Ma J; Kerbauy LN; Spratt DE; Santos FP; Perini GF; Berlin A; Chung C; Hamerschlak N; Yahalom J
    Radiother Oncol; 2017 Mar; 122(3):352-361. PubMed ID: 28104300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Central Nervous System Lymphoma.
    Löw S; Batchelor TT
    Semin Neurol; 2018 Feb; 38(1):86-94. PubMed ID: 29548055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving Treatments for Primary Central Nervous System Lymphoma.
    Ferreri AJM; Holdhoff M; Nayak L; Rubenstein JL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():454-466. PubMed ID: 31099614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary central nervous system lymphoma: status and advances in diagnosis, molecular pathogenesis, and treatment.
    Zhang Y; Zhou DB
    Chin Med J (Engl); 2020 Jun; 133(12):1462-1469. PubMed ID: 32452898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary central nervous system lymphoma.
    de Koning ME; Hof JJ; Jansen C; Doorduijn JK; Bromberg JEC; van der Meulen M
    J Neurol; 2024 May; 271(5):2906-2913. PubMed ID: 38112784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the management of primary central nervous system lymphoma.
    Sun X; Lv L; Wu Y; Cui Q; Sun S; Ji N; Liu Y
    Crit Rev Oncol Hematol; 2023 Aug; 188():104042. PubMed ID: 37277008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of primary central nervous system lymphoma.
    El Kamar FG; Abrey LE
    J Natl Compr Canc Netw; 2004 Jul; 2(4):341-9. PubMed ID: 19795597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
    Langner-Lemercier S; Houillier C; Soussain C; Ghesquières H; Chinot O; Taillandier L; Soubeyran P; Lamy T; Morschhauser F; Benouaich-Amiel A; Ahle G; Moles-Moreau MP; Moluçon-Chabrot C; Bourquard P; Damaj G; Jardin F; Larrieu D; Gyan E; Gressin R; Jaccard A; Choquet S; Brion A; Casasnovas O; Colin P; Reman O; Tempescul A; Marolleau JP; Fabbro M; Naudet F; Hoang-Xuan K; Houot R
    Neuro Oncol; 2016 Sep; 18(9):1297-303. PubMed ID: 26951382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary central nervous system lymphoma.
    Ferreri AJ; Reni M
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma.
    Basso U; Brandes AA
    Eur J Cancer; 2002 Jul; 38(10):1298-312. PubMed ID: 12091059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.